Charles Matine - Net Worth and Insider Trading
Charles Matine Net Worth
The estimated net worth of Charles Matine is at least $2 dollars as of 2024-12-01. Charles Matine is the Director of Bionik Laboratories Corp and owns about 206,985 shares of Bionik Laboratories Corp (BNKL) stock worth over $2. Details can be seen in Charles Matine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles Matine has not made any transactions after 2023-06-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles Matine
Charles Matine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles Matine owns 1 companies in total, including Bionik Laboratories Corp (BNKL) .
Click here to see the complete history of Charles Matine’s form 4 insider trades.
Insider Ownership Summary of Charles Matine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BNKL | Bionik Laboratories Corp | 2023-06-09 | director |
Charles Matine Latest Holdings Summary
Charles Matine currently owns a total of 1 stock. Charles Matine owns 206,985 shares of Bionik Laboratories Corp (BNKL) as of June 9, 2023, with a value of $2.
Latest Holdings of Charles Matine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BNKL | Bionik Laboratories Corp | 2023-06-09 | 206,985 | 0.00 | 2 |
Holding Weightings of Charles Matine
Charles Matine Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles Matine has made a total of 1 transactions in Bionik Laboratories Corp (BNKL) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Bionik Laboratories Corp is the acquisition of 180,555 shares on June 9, 2023, which cost Charles Matine around $108,333.
Insider Trading History of Charles Matine
- 1
Charles Matine Trading Performance
GuruFocus tracks the stock performance after each of Charles Matine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles Matine is -56.67%. GuruFocus also compares Charles Matine's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles Matine within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles Matine's insider trading performs compared to the benchmark.
Performance of Charles Matine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -20.63 | | | | | |
| Relative Return to S&P 500(%) | -22.96 | | | | | |
Charles Matine Ownership Network
Charles Matine Owned Company Details
What does Bionik Laboratories Corp do?
Who are the key executives at Bionik Laboratories Corp?
Charles Matine is the director of Bionik Laboratories Corp. Other key executives at Bionik Laboratories Corp include director & 10 percent owner Remi Gaston-dreyfus , director & Chairman Andre-jacques Auberton-herve , and Executive Vice President & CFO Daniel Gonsalves .
Bionik Laboratories Corp (BNKL) Insider Trades Summary
Over the past 18 months, Charles Matine made 1 insider transaction in Bionik Laboratories Corp (BNKL) with a net purchase of 180,555. Other recent insider transactions involving Bionik Laboratories Corp (BNKL) include a net purchase of 650,000 shares made by Andre-jacques Auberton-herve , a net purchase of 180,555 shares made by Remi Gaston-dreyfus ,
In summary, during the past 3 months, insiders sold 0 shares of Bionik Laboratories Corp (BNKL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Bionik Laboratories Corp (BNKL) were sold and 1,011,110 shares were bought by its insiders, resulting in a net purchase of 1,011,110 shares.
Bionik Laboratories Corp (BNKL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bionik Laboratories Corp Insider Transactions
Charles Matine Mailing Address
Above is the net worth, insider trading, and ownership report for Charles Matine. You might contact Charles Matine via mailing address: 7 Rue Gustave, Flaubert, Paris I0 75017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
